ANTHEM slid -3.1% on at day's low
Anthem Biosciences is trading at ₹772.35 as of 11:00 IST, down 2.36% for the session, with the stock pressing against its intraday low of ₹769.20. The decline comes even as the broader Nifty 50 is up 0.62%, making for a notable underperformance. The session began with a marginal gap-up of 0.12%, but selling pressure quickly took hold, pushing the price well below the previous close of ₹791.05 and keeping it anchored below the volume-weighted average price — a sign that sellers have controlled the tape through the morning.
The order book structure points to the same imbalance: the bid-ask spread is ask-heavy by 44%, meaning sell orders are stacked more aggressively than buy interest. Relative volume is elevated at 1.71 times normal, so the price move is happening on genuinely active participation rather than thin trading. The watch zone flagged by the data sits at that ₹769.20 low; a sustained break below would signal downside continuation, while any recovery back above ₹791.05 would suggest the selling is being absorbed.
The immediate backdrop is dominated by a large block deal that crossed four days ago. According to headlines from Equitypandit and CNBC TV18, shares worth ₹1,275 crore changed hands in that transaction, which initially sent the stock up 4-5%. Exchange filings show the seller as Aruna Ganesh in the "Other" category, offloading ₹1,274.7 crore on June 18 — appearing twice in the data, which likely reflects a single large transaction recorded across two legs. On the buy side of that same date, domestic institutions stepped in: HDFC Mutual Fund and Kotak Mahindra Mutual Fund each acquired ₹100 crore, while Bajaj Life Insurance and ICICI Prudential Life Insurance picked up ₹90 crore apiece. No fresh institutional deals are recorded for today's session, but the "Other SELL ₹1,275 Cr" tag in today's deals section suggests residual activity or reporting effects from that block.
Technically, the stock remains in a broader uptrend despite today's weakness. It is trading above both its 50-day and 200-day simple moving averages, with the RSI at 50.6 — neutral territory, neither oversold nor overbought. The stock sits 33.36% above its 52-week low and 11.58% below its 52-week high, so the range is relatively balanced. Returns over the past week and month are modestly negative at -0.14% and -0.61% respectively, indicating recent consolidation rather than sharp deterioration. No golden cross, death cross, or Darvas breakout patterns are active.
News flow beyond the block deal is sparse. A headline from scanx.trade five days ago noted the company confirmed no encumbrance on promoter shares for fiscal 2026 — a routine governance disclosure. Older headlines reference March-quarter earnings and a MarketsMojo rating upgrade to "Hold" from forty days ago, but nothing in the evidence pack ties directly to today's price action. No insider filings have been recorded in the past sixty days, and there is no F&O positioning data available for the stock.
What the data establishes is a stock under distribution pressure this morning, separated from the market's positive tone, with volume confirming the move. What it does not establish is a clear immediate catalyst for today's selling — the block deal is four days old, and no fresh news or institutional flow explains the renewed weakness. Traders are watching whether ₹769.20 holds or gives way.
The numbers
- Last price ₹766.15, -3.15% on the day
- Day range ₹764.40 – ₹794.70
- Opening gap +0.12%
- NIFTY moved +0.37% the same session
Signals that fired
- At day's low
- vs NIFTY +0.37%
- Below VWAP -0.79%
- Other SELL ₹1,275 Cr
Institutional activity
| Date | Side | Counterparty | Type | ₹ Cr |
|---|---|---|---|---|
| 2026-06-18 | SELL | ARUNA GANESH | Other | 1,274.7 |
| 2026-06-18 | SELL | ARUNA GANESH | Other | 1,274.7 |
| 2026-06-18 | BUY | HDFC MUTUAL FUND | MF | 100.0 |
| 2026-06-18 | BUY | KOTAK MAHINDRA MUTUAL FUND | MF | 100.0 |
| 2026-06-18 | BUY | BAJAJ LIFE INSURANCE LIMITED | Insurance | 90.0 |
| 2026-06-18 | BUY | ICICI PRUDENTIAL LIFE INSURANCE COMPANY LIMITED | Insurance | 90.0 |
Technical context
Volume ran at 2.4× its 20-day average; rsi(14) sits at 58; price is 9.4% from the 52-week high; trading above the 50-dma and 200-dma.
Recent headlines
- Anthem Biosciences Climbs 5% as Rs 1,275 Cr Block Deal Hits the Market — Equitypandit (4d ago)
- Anthem Biosciences shares rise 4% after equity worth ₹1,275 crore changes hands in block deal — CNBC TV18 (4d ago)
- Anthem Biosciences confirms no encumbrance on promoter shares in FY26 — scanx.trade (5d ago)
- Compare with — Equitymaster (8d ago)
- Anthem Biosciences Ltd (NSE:ANTHEM) Q4 2026 Earnings Call Highlights: Record Growth and ... — GuruFocus.com (32d ago)
- Anthem Biosciences Ltd Upgraded to Hold by MarketsMOJO Amid Mixed Financials and Improved Technicals — MarketsMojo (40d ago)
- ANTHEM BIOSCIENCES LTD Share Price Today - Live ANTHEM Stock Price for NSE/BSE — Upstox (48d ago)
- Anthem Biosciences Ltd (NSE:ANTHEM) Q3 2025 Earnings Call Highlights: Strong EBITDA Growth ... — GuruFocus.com (128d ago)
Sources
- Anthem Biosciences Climbs 5% as Rs 1,275 Cr Block Deal Hits the Market — Equitypandit
- Anthem Biosciences shares rise 4% after equity worth ₹1,275 crore changes hands in block deal — CNBC TV18
- Anthem Biosciences confirms no encumbrance on promoter shares in FY26 — scanx.trade
- Compare with — Equitymaster
- Anthem Biosciences Ltd (NSE:ANTHEM) Q4 2026 Earnings Call Highlights: Record Growth and ... — GuruFocus.com
- Anthem Biosciences Ltd Upgraded to Hold by MarketsMOJO Amid Mixed Financials and Improved Technicals — MarketsMojo
- ANTHEM BIOSCIENCES LTD Share Price Today - Live ANTHEM Stock Price for NSE/BSE — Upstox
- Anthem Biosciences Ltd (NSE:ANTHEM) Q3 2025 Earnings Call Highlights: Strong EBITDA Growth ... — GuruFocus.com
Keep digging
- ANTHEM — full smart-money page: F&O positioning, deals, insider filings and option chain in one place.
- Today's screens: every stock matching the same setups (buildups, breakouts, volume shockers).
- Newsroom: the other stocks in play this session.